Funder: Dept. of the Army -- USAMRAA
Due Dates: June 13, 2025 (Pre-application/LOI) | June 27, 2025 (Full application)
Funding Amounts: Up to $7M (single PI) or $8.4M (Partnering PI Option) total costs over 4 years; ~3 awards expected; total program funding ~$23.8M.
Summary: Supports extension or expansion of data collection, follow-up, and analysis for breast cancer clinical studies to increase the clinical impact of patient participation and address gaps from early trial termination or limited follow-up.
Key Information: Research teams must include at least two breast cancer consumer advocates; no clinical trials permitted.